Statistics for Terns Pharmaceuticals, (id:7888 TERN)
Valuation metrics
Market cap
484.15M
Enterprise value
112.55M
Trailing P/E (ttm)
-4.56
Forward P/E
-4.10
PEG ratio
-4.10
Price/Sales (ttm)
Price/Book (mrq)
1.33
Enterprise Value/Revenue
Enterprise Value/EBITDA
-1.13
Overview
Shares outstanding
84.94M
Float
59.43M
Shares short
4.54M
% Held by insiders
0.00%
% Held by institutions
0.98%
Average volume (10 days)
1.30M
Average volume (90 days)
Price summary
52-Week low
3.68
52-Week high
11.40
52-Week change
33.33%
Beta
-0.33
50-Day moving average
8.03
200-Day moving average
7.14
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-19.23%
Return on equity
-28.28%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-99,655,000.00
Net income to common (ttm)
-88,073,000.00
Diluted EPS (ttm)
-1.18
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
372.78M
Total cash per share (mrq)
4.39
Total debt (mrq)
1.30M
Total Debt/Equity (mrq)
0.36
Current ratio (mrq)
3.30K%
Book value per share (mrq)
4.29
Cash flow
Cash flow statement
-74,748,000.00
Levered free cash flow (LFCF)
-36,249,500.00